Program Overview
Program Overview
| 26th November - Morning | 27th November - Morning | 28th November - Morning |
|
Session 1. Mucosal Vaccines for Respiratory Disease |
Flash Poster Session |
Session 4. New Approaches for Vaccine Adjuvant Session 5. New Methods for Vaccine Delivery |
| 26th November - Afternoon | 27th November - Afternoon | 28th November - Afternoon |
|
Session 6. Cancer Vaccines and Immunotherapy |
Session 3. Models for Vaccine Development and Evaluation |
IOCV 2025 Program (DAY 1)
IOCV 2025 Day 1
Session 1. Mucosal Vaccines for Respiratory Disease
Session 2. Vectored Vaccines
Date: 26th November 2025 (Wednesday)
Time: 9:00 (CET, Basel) | 03:00 (EDT, New York) | 16:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 09:00-09:15 | Professor Sara Louise Cosby Event Chair |
Welcome from the Event Chair |
| 09:15-09:35 | Professor Peter Delputte Professor Stephanie Longet Session Chairs |
Welcome from the Session Chairs |
| 9:35-10:05 | Professor Isabelle Dimier-Poisson Keynote Speaker |
COVID Nasal Vaccine and Beyond: A New Vaccinology Platform |
| 10:05-10:30 | Dr. Fang Xu Invited Speaker |
CanSinoBIO solution for TB control: Inhaled Adenovirus (Human type 5) Vectored Tuberculosis Vaccine |
| 10:30-11:00 | Dr. Jingyou Yu Keynote Speaker |
Adenoviral-Vectored Vaccines: Challenges and Opportunities |
| 11:00-11:15 |
Xingmin Sun |
The Receptor binding domain 2 (RBD2) of binary toxin (CDT) as a promising vaccine candidate protects both mice and hamsters against CDT challenge |
| 11:15-15:00 | BREAK |
Session 6. Cancer, Vaccines and Immunotherapy
Date: 26th November 2025 (Wednesday)
Time: 15:00 (CET, Basel) | 09:00 (EDT, New York) | 22:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 15:00-15:15 | Prof. Dr. Mona O. Mohsen Prof. Dr. Seth Pincus Session Chairs |
Welcome from the Session Chairs |
| 15:15-15:35 | Prof. Dr. Daniel Speiser Keynote Speaker |
Target antigens for cancer vaccines |
| 15:35-15:55 | Dr. Simone De Brot Invited Speaker |
Evaluating Vaccine-Induced Tissue Effects Through Multiplexing and Digital Pathology |
| 15:55-16:15 |
Dr. Surojit Sarkar |
Regulation of T cell Exhaustion and Immunotherapy by Common gamma-chain cytokines and mimetics |
| 16:15-16:35 |
Dr. Carol Leung |
Chemotherapy synergizes with cancer vaccines and expands stem-like TCF1+CD8+ T cells |
| 16:35-16:55 | Dr. Wendao Liu Invited Speaker |
Single-cell immune profiling reveals potent anti-tumor immune response in virus-like particle vaccine and anti-CTLA4 treatment through lymphatic delivery |
| 16:55-17:15 | Dr. Julie Decock Invited Speaker |
Cancer/Testis Antigens as Precision Tumor Targets for Cancer Vaccines and Adoptive Cell Therapy |
| 17:15-17:30 | Arnau Solé Casaramona Selected Speaker |
Preclinical Potential of γδ T Cells in Novel Personalized Antigen-Directed Immunotherapy for Triple-Negative Breast Cancer |
| 17:30-17:45 | Yusra Zarlashat Selected Speaker |
Next-Generation Cancer Vaccines and Immunotherapy: Neo-Antigen Strategies and AI-Driven Personalization for Precision Tumor Targeting |
| 17:45-18:00 | Inesa Stonkutė Selected Speaker |
Therapeutic Cancer Vaccines Combined with Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma: A Systematic Review of Clinical Evidence |
IOCV 2025 Program (DAY 2)
IOCV 2025 Day 2
Flash Poster Session
Date: 27th November 2025 (Thursday)
Time: 9:00 (CET, Basel) | 03:00 (EDT, New York) | 16:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 09:00-09:05 | Welcome speech by MDPI host | |
| 09:05-09:10 | Mahsa Asgari Selected Poster Presenter |
Evaluation of a novel cat allergy vaccine platform based on EMV-VLPs |
| 09:10-09:15 | Anish Ghimire Selected Poster Presenter |
Programming immunity: a tetravalent mucosal nanovaccine for enhanced local and systemic antitumor responses |
| 09:15-09:20 | Mariya Borgoyakova Selected Poster Presenter |
A bivalent COVID-19 mRNA vaccine combined B-cell and T-cell immunogens elicits strong humoral and cellular immune response in mice |
| 09:20-09:25 | Muhammad Usman Selected Poster Presenter |
Biomaterial-Based Delivery Systems: Nanoparticles, Hydrogels & Microneedles in Shaping Vaccine Efficacy |
| 09:25-09:30 | Min Xuan Keh Selected Poster Presenter |
Immunogenicity Study of Chimeric Secretory IgA: TB Multi-Epitopes Protein as Vaccine Candidate in Development of Mucosal Vaccine Against Tuberculosis |
| 09:30-09:35 | Banjo Christianah Tolani Selected Poster Presenter |
Challenges and Prospects of Vectored Vaccine Platforms in the Nigerian Public Health System |
| 09:35-09:40 | Oumaima BOUNAR Selected Poster Presenter |
Acceptance of HPV vaccination among adolescent girls in the EMRO region: preliminary results of a systematic review |
| 09:40-09:45 | Verónica Araceli Márquez Escobar Selected Poster Presenter |
Assessment of Zein Nanoparticles as Carriers of SARS-CoV-2 Antigens |
| 09:45-09:50 | Carlos Hernández Selected Poster Presenter |
Generation and characterization of zein nanoparticles conjugated with folic acid as a proposal for oral vaccine nanocarriers |
| 09:50-09:55 | Luisa HELENA DE OLIVEIRA LIMA Selected Poster Presenter |
Análise da cobertura vacinal de crianças de 24 meses de idade em Teresina-PI: inquérito domiciliar |
| 09:55-10:00 | Ayesha Zahid Selected Poster Presenter |
Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations |
| 10:00-15:00 | BREAK |
Session 3. Models for Vaccine Development and Evaluation
Date: 27th November 2025 (Thursday)
Time: 15:00 (CET, Basel) | 09:00 (EDT, New York) | 21:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 15:00-15:10 | Prof. Dr. Jorge H. Leitão Session Chair |
Welcome from the Session Chair |
| 15:10-15:40 | Professor Paulo Bettencourt Keynote Speaker |
Antigen discovery for malaria vaccines using immunopeptidomics |
| 15:40-16:05 | Alexander Badten Invited Speaker |
Evaluation of Highly Conserved Burkholderia pseudomallei Proteins as pan-Burkholderia Vaccine Antigen Candidates |
| 16:05-16:20 | Qing He Selected Speaker |
Impact of Two-Dose Varicella Vaccination on Incidence in Guangzhou: An Interrupted Time Series Study |
| 16:20-16:35 | Haobo Kang Selected Speaker |
Adverse events of mRNA vaccine: mechanisms, risks and management |
| 16:35-16:50 | Eman abd elmunem Shosha Selected Speaker |
Successive efficacy evaluation of various commercial live-attenuated avian coronavirus vaccination schedules against challenge with circulating field strain of genotype 23 lineage |
| 16:50-17:05 | Isabela Karina Vilas Boas Selected Speaker |
Hepatitis B birth dose vaccination coverage in Brazil (2016–2025): a temporal analysis based on national health data |
| 17:05-17:20 | Carlos Domínguez Vargas Selected Speaker |
Conceptual Design of a Dual-Function saRNA-LNP Vaccine Encoding Mosaic HIV Antigens and Intracellular Antiviral Peptides: Framework for Therapeutic HIV Vaccination |
| 17:20-17:35 | Amany Hassan Selected Speaker |
Novel Immunopeptidomic Insights into EHEC O157:H7 Immune Evasion in Cattle: Implications for Rational T-Cell-Based Vaccine Design |
IOCV 2025 Program (DAY 3)
IOCV 2025 Day 3
Session 5. New Methods for Vaccine Delivery
Session 4. New Approaches for Vaccine Adjuvants
Date: 28th November 2025 (Friday)
Time: 9:00 (CET, Basel) | 03:00 (EDT, New York) | 16:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 09:00-09:10 | Prof. Dr. Silvio Tafuri Session Chair |
Welcome from the Session Chair |
| 09:10-09:35 |
Prof. Dr. Jose Lorenzo Valencia Martin |
Integrating enhanced vaccines and advanced delivery for Influenza control in High-Risk Patients: from innovation to population health |
| 09:35-10:00 | Professor Claudia Maria Trombetta Keynote Speaker |
Overview of Serological Techniques for Influenza Vaccine Evaluation |
| 10:00-10:20 | Dr. Antonio Di Lorenzo Invited Speakers |
New vaccine delivery systems and vaccine hesitancy: opportunities and challenges for a shifting scenery |
| 10:20-10:35 | Atieh Rezvankhah Selected Speaker |
Targeting Epstein–Barr Virus With Nanocarriers: In Vitro Evaluation of a Liposomal Candidate |
| 10:35-10:50 | Vladimir A. Yakovlev Selected Speaker |
Comparative analysis of the immunogenicity of mRNA-H5 vaccine delivered by needle-free jet injection and lipid nanoparticles |
| 10:50-11:05 | Ramireddy Bommireddy Selected Speaker |
Bivalent virus like particle (VLP)-based delivery of SARS-CoV-2 spike RBD-GM-CSF fusion protein induces durable and protective response |
| 11:05-11:20 | Fangfeng Yuan Selected Speaker |
Selection, Design and Immunogenicity Studies of ASFV Antigens for Subunit mRNA Cocktail Vaccines with Specific Immune Response Profiles |
| 11:20-11:30 | Prof. Dr. Srinivasa Reddy Bonam Session Chair |
Welcome from the Session Chair |
| 11:30-12:00 | Professor Jagadeesh Bayry Keynote Speaker |
Targeting Regulatory T Cells in Vaccination: Rationale and Strategies |
| 12:00-12:25 | Dr. Kishore R. Alugupalli Invited Speaker |
Turbo: an adjuvant central to the immunogenicity of bacterial glycoconjugate subunit vaccines |
| 12:25-12:40 | Xinyuan Chen Selected Speaker |
Mechanistic studies reveal crucial roles of inducible HSP70 in radiofrequency adjuvant effects and low-level local inflammation |
| 12:40-12:55 | Haroon Afzal Selected Speaker |
Intrinsic Adjuvant Effect of Lipoprotein Signal Peptide in a Recombinant PEDV Subunit Vaccine |